TI-I-174, a Synthetic Chalcone Derivative, Suppresses Nitric Oxide Production in Murine Macrophages via Heme Oxygenase-1 Induction and Inhibition of AP-1 |
Kim, Mi Jin
(College of Pharmacy, Yeungnam University)
Kadayat, Taraman (College of Pharmacy, Yeungnam University) Kim, Da Eun (College of Pharmacy, Yeungnam University) Lee, Eung-Seok (College of Pharmacy, Yeungnam University) Park, Pil-Hoon (College of Pharmacy, Yeungnam University) |
1 | Nussler, A. K. and Billiar, T. R. (1993) Inflammation, immunoregulation, and inducible nitric oxide synthase. J. Leukoc. Biol. 54, 171-178. DOI |
2 | Onyiah, J. C., Sheikh, S. Z., Maharshak, N., Steinbach, E. C., Russo, S. M., Kobayashi, T., Mackey, L. C., Hansen, J. J., Moeser, A. J., Rawls, J. F., Borst, L. B., Otterbein, L. E. and Plevy, S. E. (2013) Carbon monoxide and heme oxygenase-1 prevent intestinal inflammation in mice by promoting bacterial clearance. Gastroenterology 144, 789-798. DOI |
3 | Otterbein, L. E., Soares, M. P., Yamashita, K. and Bach, F. H. (2003) Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 24, 449-455. DOI ScienceOn |
4 | Park, P. H., Kim, H. S., Jin, X. Y., Jin, F., Hur, J., Ko, G. and Sohn, D. H. (2009) KB-34, a newly synthesized chalcone derivative, inhibits lipopolysaccharide-stimulated nitric oxide production in RAW 264.7 macrophages via heme oxygenase-1 induction and blockade of activator protein-1. Eur. J. Pharmacol. 606, 215-224. DOI ScienceOn |
5 | Ruan, R. S. (2002) Possible roles of nitric oxide in the physiology and pathophysiology of the mammalian cochlea. Ann. N. Y. Acad. Sci. 962, 260-274. DOI |
6 | Sasaki, T., Takahashi, T., Maeshima, K., Shimizu, H., Toda, Y., Morimatsu, H., Takeuchi, M., Yokoyama, M., Akagi, R. and Morita, K. (2006) Heme arginate pretreatment attenuates pulmonary NF-kappaB and AP-1 activation induced by hemorrhagic shock via heme oxygenase-1 induction. Med. Chem. 2, 271-274. |
7 | Sawle, P., Foresti, R., Mann, B. E., Johnson, T. R., Green, C. J. and Motterlini, R. (2005) Carbon monoxide-releasing molecules (CORMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br. J. Pharmacol. 145, 800-810. DOI ScienceOn |
8 | True, A. L., Olive, M., Boehm, M., San, H., Westrick, R. J., Raghavacha ri, N., Xu, X., Lynn, E. G., Sack, M. N., Munson, P. J., Gladwin, M. T. and Nabel, E. G. (2007) Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxide. Circ. Res. 101, 893-901. DOI ScienceOn |
9 | Wu, J., Li, J., Cai, Y., Pan, Y., Ye, F., Zhang, Y., Zhao, Y., Yang, S., Li, X. and Liang, G. (2011) Evaluation and discovery of novel synthetic chalcone derivatives as anti-inflammatory agents. J. Med. Chem. 54, 8110-8123. DOI ScienceOn |
10 | Yasui, Y., Nakamura, M., Onda, T., Uehara, T., Murata, S., Matsui, N., Fukuishi, N., Akagi, R., Suematsu, M. and Akagi, M. (2007) Heme oxygenase-1 inhibits cytokine production by activated mast cells. Biochem. Biophys. Res. Commun. 354, 485-490. DOI ScienceOn |
11 | Hsieh, C. H., Jeng, S. F., Hsieh, M. W., Chen, Y. C., Rau, C. S., Lu, T. H. and Chen, S. S. (2008) Statin-induced heme oxygenase-1 increases NF-kappaB activation and oxygen radical production in cultured neuronal cells exposed to lipopolysaccharide. Toxicol. Sci. 102, 150-159. DOI |
12 | Karki, R., Thapa, P., Kang, M. J., Jeong, T. C., Nam, J. M., Kim, H. L., Na, Y., Cho, W. J., Kwon, Y. and Lee, E. S. (2010) Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structureactivity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines. Bioorg. Med. Chem. 18, 3066-3077. DOI ScienceOn |
13 | Kim, S. H., Lee, E., Baek, K. H., Kwon, H. B., Woo, H., Lee, E. S., Kwon, Y. and Na, Y. (2013) Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents. Bioorg. Med. Chem. Lett. 23, 3320-3324. DOI |
14 | Kontogiorgis, C., Mantzanidou, M. and Hadjipavlou-Litina, D. (2008) Chalcones and their potential role in inflammation. Mini Rev. Med. Chem. 8, 1224-1242. DOI |
15 | Kwak, M. K., Itoh, K., Yamamoto, M. and Kensler, T. W. (2002) Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter. Mol. Cell. Biol. 22, 2883-2892. DOI ScienceOn |
16 | Madan, B., Batra, S. and Ghosh, B. (2000) 2'-hydroxychalcone inhibits nuclear factor-kappaB and blocks tumor necrosis factor-alpha-and lipopolysaccharide-induced adhesion of neutrophils to human umbilical vein endothelial cells. Mol. Pharmacol. 58, 526-534. DOI |
17 | Na, H. K. and Surh, Y. J. (2014) Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1. Free Radic. Biol. Med. 67, 353-365. DOI |
18 | Maines, M. D. (1997) The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37, 517-554. DOI ScienceOn |
19 | Moncada, S. and Higgs, A. (1993) The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329, 2002-2012. DOI ScienceOn |
20 | Motterlini, R., Foresti, R., Bassi, R. and Green, C. J. (2000) Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic. Biol. Med. 28, 1303-1312. DOI ScienceOn |
21 | Nguyen, T., Sherratt, P. J., Huang, H. C., Yang, C. S. and Pickett, C. B. (2003) Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J. Biol. Chem. 278, 4536-4541. DOI ScienceOn |
22 | Numazawa, S., Ishikawa, M., Yoshida, A., Tanaka, S. and Yoshida, T. (2003) Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. Am. J. Physiol. Cell Physiol. 285, C334-342. DOI ScienceOn |
23 | Ashino, T., Yamanaka, R., Yamamoto, M., Shimokawa, H., Sekikawa, K., Iwakura, Y., Shioda, S., Numazawa, S. and Yoshida, T. (2008) Negative feedback regulation of lipopolysaccharide-induced inducible nitric oxide synthase gene expression by heme oxygenase-1 induction in macrophages. Mol. Immunol. 45, 2106-2115. DOI ScienceOn |
24 | Abuarqoub, H., Foresti, R., Green, C. J. and Motterlini, R. (2006) Heme oxygenase-1 mediates the anti-inflammatory actions of 2'-hydroxychalcone in RAW 264.7 murine macrophages. Am. J. Physiol. Cell Physiol. 290, C1092-1099. DOI |
25 | Batovska, D., Parushev, S., Slavova, A., Bankova, V., Tsvetkova, I., Ninova, M. and Najdenski, H. (2007) Study on the substituents' effects of a series of synthetic chalcones against the yeast Candida albicans. Eur. J. Med. Chem. 42, 87-92. DOI ScienceOn |
26 | Alcaraz, M. J., Vicente, A. M., Araico, A., Dominguez, J. N., Terencio, M. C. and Ferrandiz, M. L. (2004) Role of nuclear factor-kappaB and heme oxygenase-1 in the mechanism of action of an anti-inflammatory chalcone derivative in RAW 264.7 cells. Br. J. Pharmacol. 142, 1191-1199. DOI ScienceOn |
27 | Avila, H. P., Smania Ede, F., Monache, F. D. and Smania, A., Jr. (2008) Structure-activity relationship of antibacterial chalcones. Bioorg. Med. Chem. 16, 9790-9794. DOI ScienceOn |
28 | Ban, H. S., Suzuki, K., Lim, S. S., Jung, S. H., Lee, S., Ji, J., Lee, H. S., Lee, Y. S., Shin, K. H. and Ohuchi, K. (2004) Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase and tumor necrosis factor-alpha by 2'-hydroxychalcone derivatives in RAW 264.7 cells. Biochem. Pharmacol. 67, 1549-1557. DOI ScienceOn |
29 | Berger, B., Rothmaier, A. K., Wedekind, F., Zentner, J., Feuerstein, T. J. and Jackisch, R. (2006) Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex. Br. J. Pharmacol. 148, 795-806. |
30 | Dijkstra, G., Blokzijl, H., Bok, L., Homan, M., van Goor, H., Faber, K. N., Jansen, P. L. and Moshage, H. (2004) Opposite effect of oxidative stress on inducible nitric oxide synthase and haem oxygenase-1 expression in intestinal inflammation: anti-inflammatory effect of carbon monoxide. J. Pathol. 204, 296-303. DOI ScienceOn |
31 | Wang, W. P., Guo, X., Koo, M. W., Wong, B. C., Lam, S. K., Ye, Y. N. and Cho, C. H. (2001) Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G586-594. DOI |
32 | Karki, R., Thapa, P., Yoo, H. Y., Kadayat, T. M., Park, P. H., Na, Y., Lee, E., Jeon, K. H., Cho, W. J., Choi, H., Kwon, Y. and Lee, E. S. (2012) Dihydroxylated 2,4,6-triphenyl pyridines: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study. Eur. J. Med. Chem. 49, 219-228. DOI ScienceOn |
33 | Cullinan, S. B., Zhang, D., Hannink, M., Arvisais, E., Kaufman, R. J. and Diehl, J. A. (2003) Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol. Cell. Biol. 23, 7198-7209. DOI ScienceOn |
34 | Gibaldi, M. (1993) What is nitric oxide and why are so many people studying it? J. Clin. Pharmacol. 33, 488-496. DOI |
35 | Dinkova-Kostova, A. T., Massiah, M. A., Bozak, R. E., Hicks, R. J. and Talalay, P. (2001) Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc Natl Acad Sci U.S.A. 98, 3404-3409. DOI ScienceOn |
36 | Foresti, R., Hoque, M., Monti, D., Green, C. J. and Motterlini, R. (2005) Differential activation of heme oxygenase-1 by chalcones and rosolic acid in endothelial cells. J. Pharmacol. Exp. Ther. 312, 686-693. |